Dr. Perin is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
6624 Fannin St
Ste 2600
Houston, TX 77030Phone+1 713-790-9401Fax+1 713-790-0353
Summary
- I am a board certified interventional cardiologist specialized in performing coronary and peripheral interventions. I have achieved a level of excellence in these procedures and serve as the Director of the cardiac catheterization laboratory at Baylor St. Lukes Medical Center.
I have had a long-term interest in research and after founding the Stem Cell Center at the Texas Heart Institute in 2000 have developed stem cell treatments for cardiovascular disease over the last 15 years. I am a worldwide leader in stem cell therapy for heart failure and widely published in the field.
My institutional leadership lead to my appointment as Medical Director of the Texas Heart Institute in 2018.
Education & Training
- Instituto de Cardiologia Fundação Universitária de CardiologiaPhD, Cardiology, 1993 - 1995
- Baylor College of Medicine/Texas Heart Institute/Baylor St Luke's Medical CenterFellowship, Cardiovascular Disease, 1988 - 1991
- University of Miami/Jackson Health SystemResidency, Internal Medicine, 1985 - 1988
- Federal University of Rio Grande do Sul School of MedicineClass of 1983
Certifications & Licensure
- TX State Medical License 1991 - 2026
- FL State Medical License 1987 - 1998
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Interventional Cardiology
Awards, Honors, & Recognition
- McNair Scholar Texas Heart Institute
- America's Top Doctors Castle Connolly, 2006-2014
- Top Doctors:SE Texas Castle Connolly, 2013
- Join now to see all
Clinical Trials
- Autologous Stem Cells for Cardiac Angiogenesis (FOCUS HF) Start of enrollment: 2004 Apr 01
- NEXUS Study for the Treatment of de Novo Native Coronary Artery Lesions Start of enrollment: 2004 Apr 01
- CYPHERTM Stent Post-Marketing Surveillance Registry (US-PMS) Start of enrollment: 2003 Aug 01
- Join now to see all
Publications & Presentations
PubMed
- Mesenchymal precursor cells reduce mortality and major morbidity in ischaemic heart failure with inflammation: DREAM-HF.Emerson C Perin, Kenneth M Borow, Timothy D Henry, Margaret Jenkins, Olga Rutman
European Journal of Heart Failure. 2024-11-26 - 5 citationsHeart Rate Variability Measurement through a Smart Wearable Device: Another Breakthrough for Personal Health Monitoring?Ke Li, Cristiano Cardoso, Angel Moctezuma-Ramirez, Abdelmotagaly Elgalad, Emerson Perin
International Journal of Environmental Research and Public Health. 2023-12-06 - 3 citationsGene therapy for diabetic foot ulcers: Interim analysis of a randomised, placebo-controlled phase 3 study of VM202 (ENGENSIS), a plasmid DNA expressing two isoforms of...Emerson Perin, Lacey Loveland, Joseph Caporusso, Cyaandi Dove, Travis Motley
International Wound Journal. 2023-11-01
Press Mentions
- Dr. Perin Leads DREAM-HF Trial – Demonstrating the Life-Saving Potential of Cell TherapyDecember 3rd, 2024
- Revascor Improves Survival and Reduces Major Morbidity in High-Risk Ischemic Heart Failure Patients with InflammationDecember 2nd, 2024
- Revascor Improves Survival and Reduces Major Morbidity in High-Risk Ischemic Heart Failure Patients with InflammationDecember 2nd, 2024
- Join now to see all
Grant Support
- Combined Stem Cell And Assist Device Therapy For Heart FailureNational Heart, Lung, And Blood Institute2010–2011
- Gadonanotubes As New MRI Nanolabels For Stem Cell TrackingNational Institute Of Biomedical Imaging And Bioengineering2009–2010
Professional Memberships
- Member
- Fellow
Other Languages
- Portuguese, Spanish
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: